Erie, PA, United States of America

Sarah C Abbot


 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Erie, PA (US) (2012)
  • San Francisco, CA (US) (2012)

Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah C Abbot

Introduction

Sarah C Abbot is a prominent inventor based in Erie, PA (US). She has made significant contributions to the field of antiviral compounds, particularly in the development of treatments for Hepatitis C. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, one notable invention involves heterocyclic antiviral compounds. These compounds have the formula A-R, where A is a heteroaryl and R is a specific chemical structure. This invention focuses on Hepatitis C virus NS5b polymerase inhibitors. Additionally, it discloses compositions and methods for treating HCV infections and inhibiting HCV replication. Another patent includes dihydroquinone and dihydronaphthridine inhibitors of JNK, which are effective modulators of JNK.

Career Highlights

Sarah C Abbot is currently associated with Roche Palo Alto LLC, where she continues to advance her research in antiviral therapies. Her innovative work has positioned her as a key figure in the development of new treatments for viral infections.

Collaborations

Throughout her career, Sarah has collaborated with notable colleagues, including Geneviève N Boice and Bernd Buettelmann. These collaborations have further enhanced her research and contributions to the field.

Conclusion

In summary, Sarah C Abbot's innovative work in antiviral compounds has made a significant impact on the treatment of Hepatitis C. Her patents reflect her dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…